MPG.eBooks - Search Results

Cover Image

61

CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasi...

Published 2018

CADTH

Cover Image

62

CADTH Canadian Drug Expert Committee final recommendation: Mifepristone and misoprostol (Mifegymiso -- Celopharma Inc.) : indication: medical termination of pregnancy

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

63

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

Cover Image

64

CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

65

CADTH Canadian Drug Expert Committee recommendation: Budesonide (Jorveza--Avir Pharma Inc.) : indication : eosinophilic esophagitis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

66

CADTH Canadian Drug Expert Committee recommendation: Onasemnogene abeparvovec (Zolgensma -- Novartis Pharmaceuticals Canada Inc.) : indication: spinal muscular atrophy

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

67

CADTH Canadian Drug Expert Committee recommendation: Ranolazine (Corzyna -- KYE pharmaceuticals Inc.) : indication: patients with stable angina pectoris who are inadequately contro...

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

68

CADTH Canadian Drug Expert Committee recommendation: Sodium zirconium cyclosilicate (Lokelma -- Astrazeneca Canada Inc.) : indication: hyperkalemia

Published 2020

CADTH

Cover Image

69

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2020

CADTH

Cover Image

70

CADTH Canadian Drug Expert Committee recommendation: Glucagon nasal powder (Baqsimi -- Eli Lilly Canada Inc) : indication: for the treatment of severe hypoglycemia (SH) reactions w...

Published 2020

CADTH

Cover Image

71

CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

72

CADTH Canadian drug expert committee recommendation: Telotristat ethyl (Xermelo -- Ipsen Biopharmaceuticals Canada Inc) : indication : for the treatment of refractory carcinoid syn...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

73

CADTH Canadian drug expert committee recommendation: Doravirine (Pifeltro -- Merck Canada Inc.) : indication: in combination with other antiretroviral medicinal products, for the t...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

74

CADTH Canadian drug expert committee recommendation: Doravirine/Lamivudine/Tenofovir disoproxil fumarate (Delstrigo -- Merck Canada Inc.) : indication: as a complete regimen for th...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

75

CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

76

CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

77

CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

78

CADTH Canadian Drug Expert Committee final recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

79

CADTH Canadian Drug Expert Review Committee final recommendation: Riociguat (Adempas - Bayer HealthCare Inc.) : indication: pulmonary arterial hypertension

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

80

CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy

Published 2016

Canadian Agency for Drugs and Technologies in Health

1
2
3
4
5
6
7
8
9
10